Stock News

Carnegie Capital Asset Management Trimmed Novo (NVO) Holding By $305,450; Last Week Sony (SNE) Analysts

Among 7 analysts covering Sony Corp (NYSE:SNE), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Sony Corp had 13 analyst reports since August 16, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 1 by Jefferies. The stock of Sony Corporation (NYSE:SNE) has “Outperform” rating given on Wednesday, April 26 by Bernstein. Jefferies maintained Sony Corporation (NYSE:SNE) on Monday, October 23 with “Buy” rating. Citigroup downgraded Sony Corporation (NYSE:SNE) on Monday, September 11 to “Neutral” rating. The firm earned “Neutral” rating on Thursday, April 21 by JP Morgan. As per Friday, September 4, the company rating was maintained by Nomura. The rating was maintained by JP Morgan on Sunday, August 16 with “Overweight”. The rating was upgraded by JP Morgan to “Overweight” on Monday, April 24. As per Wednesday, September 13, the company rating was maintained by Jefferies. The stock of Sony Corporation (NYSE:SNE) earned “Buy” rating by Jefferies on Friday, June 9. See Sony Corporation (NYSE:SNE) latest ratings:

13/12/2017 Broker: Jefferies Rating: Buy New Target: $61.79 Maintain
23/10/2017 Broker: Jefferies Rating: Buy New Target: $45.74 Maintain
13/09/2017 Broker: Jefferies Rating: Buy New Target: $45.74 Maintain
11/09/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Downgrade
01/08/2017 Broker: Jefferies Rating: Buy New Target: $45.7400 Maintain

Carnegie Capital Asset Management Llc decreased Novo (NVO) stake by 4.97% reported in 2017Q3 SEC filing. Carnegie Capital Asset Management Llc sold 6,109 shares as Novo (NVO)’s stock rose 15.20%. The Carnegie Capital Asset Management Llc holds 116,760 shares with $5.86M value, down from 122,869 last quarter. Novo now has $136.14B valuation. The stock increased 0.25% or $0.14 during the last trading session, reaching $56.55. About 631,243 shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since January 18, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

The stock decreased 1.08% or $0.54 during the last trading session, reaching $49.28. About 381,152 shares traded. Sony Corporation (NYSE:SNE) has risen 36.68% since January 18, 2017 and is uptrending. It has outperformed by 19.98% the S&P500.

Sony Corporation designs, develops, makes, and sells electronic equipment, instruments, and devices for consumer, professional, and industrial markets worldwide. The company has market cap of $64.95 billion. It offers LCD televisions, optical pickups, mobile phones, tablets, audio equipment and video conference systems, batteries, broadcast and professional-use video equipment, and DVD-players/recorders; and Blu-ray Disc players and recorders, ROMs, CDs, DVDs, and UMDs. It has a 27.14 P/E ratio. The firm also provides Internet broadband network services to subscribers, as well as creates and distributes content through its portal services to various electronics product platforms, such as PCs and mobile phones; and interchangeable lens cameras, compact digital cameras, and consumer and professional video cameras, as well as display products comprising projectors and medical equipment.

Carnegie Capital Asset Management Llc increased Vanguard Specialized Portfol (VIG) stake by 3,923 shares to 37,736 valued at $3.67M in 2017Q3. It also upped Twitter Inc (NYSE:TWTR) stake by 42,350 shares and now owns 104,175 shares. Pra Health Sciences Inc was raised too.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 20 analyst reports since August 28, 2015 according to SRatingsIntel. The firm earned “Strong Buy” rating on Monday, October 19 by Jyske Bank. The rating was upgraded by JP Morgan to “Neutral” on Friday, December 29. The company was upgraded on Friday, August 28 by Zacks. Bank of America downgraded the stock to “Underperform” rating in Friday, October 28 report. As per Friday, December 1, the company rating was upgraded by Morgan Stanley. HSBC upgraded the stock to “Hold” rating in Wednesday, August 31 report. Bank of America upgraded the shares of NVO in report on Wednesday, December 6 to “Buy” rating. The stock has “Neutral” rating by Citigroup on Monday, October 31. BNP Paribas upgraded Novo Nordisk A/S (NYSE:NVO) on Tuesday, September 13 to “Outperform” rating. The firm earned “Buy” rating on Tuesday, December 6 by UBS.

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on February, 1. They expect $0.56 earnings per share, up 12.00% or $0.06 from last year’s $0.5 per share. NVO’s profit will be $1.35 billion for 25.25 P/E if the $0.56 EPS becomes a reality. After $0.62 actual earnings per share reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts -9.68% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *